Case File
efta-efta01020517DOJ Data Set 9OtherDS9 Document EFTA01020517
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta01020517
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
To: Jeffrey Epstein [email protected]>
Subject: basis thesis on neurotramission
Date: Sun, 07 Oct 2018 21:20:06 +0000
Just like genetic code is something common to all life forms, I believe intracellular
communication is too. Like there is a common chemical language that all living things use
to "talk" between cells. Most ppl say plants don't have a nervous system because they
don't have synapses or nerves but it turns out their cells communicate using exactly the
same chemicals. Why else would plants have dopamine, acetylcholine, serotonin,
norepinephrine etc. They do. I'd like to study WHAT they do with these neurotransmitters
using neuroimaging, specifically PET and fMRI to understand in vivo irritative (excitatory)
function. The spatial resolution isn't great but I think it prove the point that intracellular
communication is preserved at the cellular level. It's been hard to convince plant people
to do "neuro" studies but ultimately I want to try move away from "neuro" perspective
and just think about how cells communicate. We still don't know how anesthesia works.
We still don't know a ton of things but I think if we can decipher the cellular/chemical
communication language we will find it is preserved but just applies differently in
different anatomy. Same physiology. That's physics right? Same rules apply to
everyone. The fact that the biochemistry is exactly the same says something. Dopamine
looks like dopamine, always.
I've written up a 2 page proposal. So far, plant scientists have either responded "no
thanks" or not responded at all. I will keep trying, and I've identified s a few groups that
have created plant focused imaging (PET and fMRI) but they aren't using it for these
purposes. My friend at Stanford is a neurotransmitter expert and he's the Vice Chair of
Psychiatry and a little crazy (Rob Malema) I suspect he would help me develop the idea a
little but I still need experimental partners. Given that you have to develop imaging
protocols and for PET you have have tracers, experiments are less complicated but they
are still more expensive that bench work. I'd say to do each series of scans would cost
between $3-5K for each plant species looking at each neurotransmitter and you would
need a few plants as a controls. So if you did the 5 basic neurotransmitters with 3 plants
each that would be somewhere between $45 and $75K just for the experiments and not
all the staff time and university taxes etc. So I would say to get this done you might need
$125-150K and probably 3-6 months.
This will tell you resting neurotransmitter function in plants. Nothing about what happens
when you stress it.
If there is left over, you might try to image an overoxygenated plant and an over CO2
plant to see how this affects function and metabolism. Or you could anesthetize the
plants and see what it does to a selected neurotransmitter or set of neurotransmitters. I
don't understand why you can't image all the biogenic amines with one tracer but I guess
it's because I'm not a biochemist. You should be able to - well maybe not histamine but
all the others.
My guess is that once the "team" (imaginary team that I haven't been able to rally yet)
gets facile with plant neuroimaging it will get super easy and cheap. Activation energy is
always high when trying something new.
EFTA01020517
Let me know if I should keep looking. I can try Brookhaven (government lab but not
dedicated plant scanner - or the other guys I sent you last night).
EFTA01020518
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.